cyclin-dependent kinase inhibitors (Cyclacel)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecyclin-dependent kinase inhibitors (Cyclacel)
Drug Alias Namecyclin-dependent kinase inhibitors (Cycalcel)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsAutoimmune DiseasesGlomerulonephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCyclacel Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCyclacel Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesGlomerulonephritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A